Form 8-K - Current report:
SEC Accession No. 0001104659-20-089624
Filing Date
2020-08-03
Accepted
2020-08-03 16:10:50
Documents
12
Period of Report
2020-07-28
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2026349d1_8k.htm   iXBRL 8-K 34563
  Complete submission text file 0001104659-20-089624.txt   211187

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vygr-20200728.xsd EX-101.SCH 3219
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20200728_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20200728_pre.xml EX-101.PRE 22732
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2026349d1_8k_htm.xml XML 3598
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 201069331
SIC: 2836 Biological Products, (No Diagnostic Substances)